Abstract
In January 2005 Australia implemented the Australia?
United States Free Trade Agreement (AUSFTA).
The agreement had placed domestic health
policy and the Pharmaceutical Benefits Scheme
(PBS) in particular, on the trade negotiating table.
At the time Australians were told the PBS would
not be undermined, but why was it included in a
trade agreement? This article argues that recent
reforms to the PBS partially delivered on an issue
that the US has compelled its trade negotiators to
ensure since 2002: the elimination of reference
pricing. In Australia, reference pricing, as used by
the PBS, had been credited with obtaining money
when buying new medicines.
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献